SUBSEQUENT EVENTS (Details) - Innovative Cellular Therapeutics - Subsequent Event	May 10, 2017 USD ($) $ / shares shares
Subsequent Event [Line Items]
License agreement, initial payment	$ 6,000,000.0
License agreement, days within effective date of agreement initial payment due	60 days
License agreement, contingent consideration, liability	$ 5,000,000.0
License agreement, contingent consideration, asset	$ 8,000,000.0
Common Stock
Subsequent Event [Line Items]
Warrants issued (in shares) | shares	2.55
Exercise price per share (in dollars per share) | $ / shares	$ 0.01